NO339322B1 - Formuleringer inneholdende cynara scolymus og phaseolus vulgaris ekstrakter som er nyttige i behandlingen av fedme - Google Patents

Formuleringer inneholdende cynara scolymus og phaseolus vulgaris ekstrakter som er nyttige i behandlingen av fedme Download PDF

Info

Publication number
NO339322B1
NO339322B1 NO20100527A NO20100527A NO339322B1 NO 339322 B1 NO339322 B1 NO 339322B1 NO 20100527 A NO20100527 A NO 20100527A NO 20100527 A NO20100527 A NO 20100527A NO 339322 B1 NO339322 B1 NO 339322B1
Authority
NO
Norway
Prior art keywords
extract
cynara scolymus
phaseolus vulgaris
extracts
obesity
Prior art date
Application number
NO20100527A
Other languages
English (en)
Norwegian (no)
Other versions
NO20100527A1 (no
Inventor
Paolo Morazzoni
Gabriele Fontana
Andrea Giori
Ezio Bombardelli
Massimo Ronchi
Cesare Ponzone
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO20100527A1 publication Critical patent/NO20100527A1/no
Publication of NO339322B1 publication Critical patent/NO339322B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20100527A 2007-03-07 2010-04-14 Formuleringer inneholdende cynara scolymus og phaseolus vulgaris ekstrakter som er nyttige i behandlingen av fedme NO339322B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90532007P 2007-03-07 2007-03-07
EP07425132A EP1967198B1 (en) 2007-03-07 2007-03-07 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity
PCT/EP2008/001787 WO2008107184A1 (en) 2007-03-07 2008-03-06 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity

Publications (2)

Publication Number Publication Date
NO20100527A1 NO20100527A1 (no) 2010-05-19
NO339322B1 true NO339322B1 (no) 2016-11-28

Family

ID=38229761

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20100527A NO339322B1 (no) 2007-03-07 2010-04-14 Formuleringer inneholdende cynara scolymus og phaseolus vulgaris ekstrakter som er nyttige i behandlingen av fedme

Country Status (19)

Country Link
US (2) US7887854B2 (enExample)
EP (1) EP1967198B1 (enExample)
JP (1) JP5355424B2 (enExample)
KR (1) KR101456555B1 (enExample)
CN (1) CN101641111B (enExample)
AT (1) ATE431155T1 (enExample)
AU (1) AU2008224057B2 (enExample)
BR (1) BRPI0808563B1 (enExample)
CA (1) CA2680078C (enExample)
DE (1) DE602007001128D1 (enExample)
DK (1) DK1967198T3 (enExample)
ES (1) ES2323815T3 (enExample)
IL (1) IL200709A (enExample)
NO (1) NO339322B1 (enExample)
PL (1) PL1967198T3 (enExample)
PT (1) PT1967198E (enExample)
RU (1) RU2453323C2 (enExample)
SI (1) SI1967198T1 (enExample)
WO (1) WO2008107184A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052450A1 (it) * 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
CN105816498A (zh) 2009-04-27 2016-08-03 玫琳凯有限公司 植物性抗痤疮制剂
EP2345646A1 (en) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR101330190B1 (ko) 2011-09-20 2013-11-15 (주)그린솔루션스 하고초 추출물의 헴 옥시게나아제-1 발현 조절을 통한 지방 생성 억제용 화장료 조성물
US9138401B2 (en) * 2011-12-19 2015-09-22 Mary Kay Inc. Combination of plant extracts to improve skin tone
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
ITMI20121727A1 (it) * 2012-10-12 2014-04-13 Indena Spa Formulazioni per il trattamento e la prevenzione dell'obesita'
ITMI20121749A1 (it) * 2012-10-16 2014-04-17 Indena Spa Estratti di helianthus annuus utili nel trattamento della sindrome metabolica e nella diminuzione dell'indice glicemico di alimenti e procedimento per la loro preparazione e composizioni che li contengono
EP3116469B1 (en) 2014-03-10 2018-10-03 Mary Kay, Inc. Skin lightening compositions
DE202014005450U1 (de) * 2014-07-04 2015-10-06 Ursapharm Arzneimittel Gmbh Lactosefreies Arzneimittel
US20160302451A1 (en) * 2015-04-16 2016-10-20 Michael Hudnall Medical Food for Patients with Chronic Liver Disease
FR3075570B1 (fr) 2017-12-22 2020-01-03 Agro Innovation International Stimulation de la nitrification d'un sol avec des compositions comprenant un extrait de plante
IT201900000367A1 (it) * 2019-01-10 2020-07-10 Altergon Sa Composizioni comprendenti un peptide in grado di stimolare la via del segnale gprc6a-dipendente
CN110433280A (zh) * 2019-09-11 2019-11-12 周口师范学院 植物血凝素在制备预防或治疗肥胖药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
ITMI20052450A1 (it) 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CELLENO L ET AL: "A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women" INTERNATIONAL JOURNAL OF MEDICAL SCIENCES 26 JAN 2007 AUSTRALIA, vol. 4, no. 1, 26 January 2007 (2007-01-26), side 45-52, Dated: 01.01.0001 *
NAZNI P ET AL: "Hypoglycemic and hypolipidemic effect of Cynara scolymus among selected type 2 diabetic individuals" PAKISTAN JOURNAL OF NUTRITION 2006 PAKISTAN, vol. 5, no. 2, 2006, side 147-151, Dated: 01.01.0001 *
TORMO M A ET AL: "HYPOGLYCAEMIC AND ANOREXIGENIC ACTIVITIES OF AN ALPHA-AMYLASE INHIBITOR FROM WHITE KIDNEY BEANS (PHASEOLUS VULGARIS) IN WISTAR RATS" BRITISH JOURNAL OF NUTRITION, CAMBRIDGE UNIVERSITY PRESS, CAMBRIDGE, GB, vol. 92, no. 5, November 2004 (2004-11), pages 785-790, Dated: 01.01.0001 *

Also Published As

Publication number Publication date
CA2680078C (en) 2016-12-06
WO2008107184A1 (en) 2008-09-12
PT1967198E (pt) 2009-06-15
HK1121694A1 (en) 2009-04-30
CN101641111A (zh) 2010-02-03
US20080220097A1 (en) 2008-09-11
KR20090118051A (ko) 2009-11-17
DK1967198T3 (da) 2009-08-10
EP1967198B1 (en) 2009-05-13
DE602007001128D1 (de) 2009-06-25
AU2008224057B2 (en) 2012-07-19
SI1967198T1 (sl) 2009-08-31
BRPI0808563A2 (pt) 2014-09-02
BRPI0808563B1 (pt) 2018-02-14
KR101456555B1 (ko) 2014-10-31
CA2680078A1 (en) 2008-09-12
CN101641111B (zh) 2012-05-23
AU2008224057A1 (en) 2008-09-12
JP2010520246A (ja) 2010-06-10
IL200709A (en) 2013-07-31
US20100136145A1 (en) 2010-06-03
JP5355424B2 (ja) 2013-11-27
PL1967198T3 (pl) 2009-10-30
IL200709A0 (en) 2010-05-17
US7887855B2 (en) 2011-02-15
US7887854B2 (en) 2011-02-15
NO20100527A1 (no) 2010-05-19
RU2453323C2 (ru) 2012-06-20
ES2323815T3 (es) 2009-07-24
RU2009133338A (ru) 2011-03-10
ATE431155T1 (de) 2009-05-15
EP1967198A1 (en) 2008-09-10

Similar Documents

Publication Publication Date Title
NO339322B1 (no) Formuleringer inneholdende cynara scolymus og phaseolus vulgaris ekstrakter som er nyttige i behandlingen av fedme
Muhammad et al. A review on promising phytochemical, nutritional and glycemic control studies on Moringa oleifera Lam. in tropical and sub-tropical regions
Das et al. Okra and its various applications in drug delivery, food technology, health care and pharmacological aspects-a review
JP2008507486A (ja) 生理活性組成物
CN102058631B (zh) 沙棘叶提取物制剂及其制备方法
US11266668B2 (en) Dietary supplement for glycemia control and diabetes prevention
Rajalakshmi et al. Validation of Anti-diabetic Potential of Avirai kudineer a Siddha herbal formulation-A Review
US10757961B2 (en) Dietary supplement for glycemia control and diabetes prevention
EP1583547A1 (en) Anti-obesity ingretients from medicinal plants and their composittion
US10220067B2 (en) Extracts of Cyclanthera pedata and formulations and uses thereof
Afsharmanesh et al. Iranian Medicinal Plants in Diabetes Management: A Narrative Review of Traditional Herbal Remedies and Their Hypoglycemic Effects
KR20090126469A (ko) 혈당 강하용 생약 조성물
Tebani et al. Journal of Molecular and Pharmaceutical Sciences
JP2009269896A (ja) 抗糖尿病食品または医薬品素材及び抗糖尿病食品または医薬品
Zim Effect of okra (Abelmoschus esculentus) mucilage on glucose level and lipid profile of alloxan-induced diabetic mice
Dunican et al. Endocrine Disorders
KR20240083130A (ko) 소리쟁이 추출물 또는 이의 분획물을 포함하는 당뇨병의 예방 또는 치료용 조성물
HK1121694B (en) Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity
PR et al. International Journal of Pharma Research and Technology
LATIF et al. Potential Health Benefits of Fenugreek Leaves
KR20130048584A (ko) 수리취 식이섬유를 포함하는 변비 개선용 조성물
KR20160052827A (ko) 혈당저하, 체중감소 및 혈압개선용 건강기능식품

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
MM1K Lapsed by not paying the annual fees